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A B S T R A C T
Question: Does the use of an oscillating positive expiratory pressure (PEP) device reduce postoperative
pulmonary complications in thoracic and upper abdominal surgical patients? Design: A multi-centre,
parallel-group, randomised controlled trial with intention-to-treat analysis, blinding of some outcomes,
and concealed allocation. Participants: A total of 203 adults after thoracic or upper abdominal surgery
with general anaesthesia. Intervention: Participants in the experimental group used an oscillating PEP
device, thrice daily for 5 postoperative days. Both the experimental and control groups received standard
medical postoperative management and early mobilisation. Outcome measures: Fever, days of
antibiotic therapy, length of hospital stay, white blood cell count, and possible adverse events were
recorded for 28 days or until hospital discharge. Results: The 99 participants in the experimental group
and 104 in the control group were well matched at baseline and there was no loss to follow-up. Fever
affected a signiﬁcantly lower percentage of the experimental group (22%) than the control group (42%),
with a RR of 0.56 (95% CI 0.36 to 0.87, NNT 6). Similarly, length of hospital stay was signiﬁcantly shorter
in the experimental group, at 10.7 days (SD 8.1), than in the control group, at 13.3 days (SD 11.1); the
mean difference was 2.6 days (95% CI 0.4 to 4.8). The groups did not differ signiﬁcantly in the need for
antibiotic therapy, white blood cell count or total expense of treatment. Conclusion: In adults
undergoing thoracic and upper abdominal surgery, postoperative use of an oscillating PEP device
resulted in fewer cases of fever and shorter hospital stay. However, antibiotic therapy and total hospital
expenses were not signiﬁcantly reduced by this intervention. Trial registration: NCT00816881. [Zhang
X-y, Wang Q, Zhang S, Tan W, Wang Z, Li J (2015) The use of a modiﬁed, oscillating positive
expiratory pressure device reduced fever and length of hospital stay in patients after thoracic and
upper abdominal surgery: a randomised trial. Journal of Physiotherapy 61: 16–20]
 2014 Published by Elsevier B.V. on behalf of Australian Physiotherapy Association. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Following both thoracic and upper abdominal surgical proce-
dures, postoperative pulmonary complications (PPCs) are fre-
quently observed and are still a major contributor to the overall
risk of surgery.1 A recent Australian study reported that PPCs affect
13% of patients undergoing upper abdominal laparotomy.2 Risk
factors for PPCs are: duration of anaesthesia, surgical category,
current smoking, respiratory comorbidity, and predicted maximal
oxygen uptake.3 Preoperative physiotherapy interventions,4 par-
ticularly inspiratory muscle training,5 decrease the risk of PPCs.
Postoperatively, early mobilisation is recommended to minimise
PPCs.2
Many pre-operative and post-operative physiotherapy inter-
ventions are not yet available or accepted in most hospitals in
China. Postoperatively, early mobilisation is used. Currently in
China, no other standardised physiotherapy and respiratory care is
provided during the postoperative period. With regard tohttp://dx.doi.org/10.1016/j.jphys.2014.11.013
1836-9553/ 2014 Published by Elsevier B.V. on behalf of Australian Physiotherapy A
creativecommons.org/licenses/by-nc-nd/3.0/).postoperative respiratory interventions, some hospitals use a
traditional technique where the patients regularly blow up a
balloon after the operation until mobilisation is re-established.
This technique is a form of respiratory exercise that is typically
used for individuals at high risk of PPCs.
Oscillating positive expiratory pressure (PEP) devices have been
shown to assist mucus clearance in a number of respiratory
diseases, including: cystic ﬁbrosis,6–9 chronic obstructive pulmo-
nary disease,10,11 asthma,12 diffuse panbronchiolitis13 and bron-
chiectasis.14,15 In some of these studies, there is also some evidence
that use of the oscillating PEP device may help to improve lung
expansion, although themechanism is unclear. Thoracic and upper
abdominal surgical patients at risk of PPCs may beneﬁt from an
intervention that facilitates the clearance of retained secretions
with a possible additional effect on lung expansion.
The hypothesis of the present study was that regular use of a
hand-held oscillating PEP device might improve respiratory
management in patients after thoracic or upper abdominalssociation. This is an open access article under the CC BY-NC-ND license (http://
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Figure 1. The oscillating PEP device was modiﬁed by the addition of a ﬂexible
adaptor inserted between the oscillating valve and the mouthpiece. This was done
so that the participants could use it at the required angle while in any body position
and without any uncomfortable sensation of dental vibration.
Research 17surgery. Therefore, the research question for the present study
was:
In patients who have undergone thoracic or upper abdominal
surgery, what is the effect of regular postoperative use of an
oscillating PEP device on fever, white cell count, length of




A randomised trial with intention-to-treat analysis, blinding of
assessors for some outcomes, and concealed allocation was
undertaken. Preoperatively, patients were informed about the
study protocol and their willingness to participate was deter-
mined. Those who remained willing and eligible to participate
postoperatively were enrolled and randomised by one of the study
investigators. On the ﬁrst postoperative day, eligible patients were
randomly allocated to an experimental or control group, with each
allocation removed from a sealed, consecutively numbered,
opaque envelope by a research assistant. Outcomes were
measured up to 28 days postoperatively or until discharge from
hospital.
Before the study was registered and commenced, the principal
investigators from each centre reached consensus on the study
protocol. Study inspectors, who were organised and instructed by
the principal investigator from Shanghai Tenth People’s Hospital,
conducted site visits andmade phone calls to ensure study quality.
Participants, therapists and centres
Adults aged 18 to 80 years were eligible to participate if they
were undergoing thoracic or upper abdominal surgery with
tracheal intubation under general anaesthesia and were extubated
within 24 hours postoperatively. Exclusion criteria were: inability
to use the oscillating PEP device (eg, due to decreased conscious-
ness or intellectual disability); advanced cancer; diffuse interstitial
lung disease; systolic blood pressure 180 mmHg; diastolic blood
pressure  110 mmHg; and severe cardiac, hepatic, renal,
circulatory or endocrine dysfunction.
The investigators who administered the oscillating PEP devices
and taught participants to use themwere physicians or respiratory
therapists. These investigators received consistent instructions in
the use of the devices via the study protocol.
Three hospitals recruited participants for the present study. The
co-ordinating centre was the Shanghai Tenth People’s Hospital,
Tongji University School of Medicine. The other centres were the
Shanghai Jiangong Hospital and the Shanghai Putuo District Centre
Hospital.
Interventions
Participants who were randomised to the experimental group
were instructed to use an oscillating PEP device.a The device is
required to be held in a particular position with respect to gravity.
Given that the participants may have been limited in the positions
that they could adopt in the early postoperative period, the device
was modiﬁed by the addition of some wide-bore connector tubing
used as a ﬂexible adaptor, which was inserted between the
oscillating valve and the mouthpiece, as shown in Figure 1. This
allowed the participants to use the device at the required angle
whilst in any body position and avoided any uncomfortable
sensation of dental vibration.
Participants were instructed to take a deep breath and then to
exhale through the device actively but not forcefully. The
participants were also instructed to adjust the position of the
device relative to gravity in order to yield the strongest feeling ofthoracic vibration during exhalation through the device. The
procedure was repeated for ﬁve to ten breaths over a 5-minute
period, three times a day, for the ﬁrst 5 postoperative days. The
following schedule was recommended: after waking up in the
morning, after an afternoon nap, and before going to bed in the
evening. Participants were instructed to avoid having a full
stomach for the breathing sessions. Participants were encouraged
to cough up sputum during the breathing sessions.
Routine medical management and early mobilisation were
provided to the participants in both groups, as appropriate and
according to each patient’s postoperative condition. No other
routine physiotherapy, such as standardised thoracic expansion
exercises,16 was administered to both groups, as this is not
routinely available in the participating hospitals. Therefore, the
control group had no other physiotherapy, unless a physician
speciﬁcally ordered it after the development of a PPC.
Due to the unavailability of a convincing sham, the control
group did not undertake sham training; therefore, the participants
were unblinded.
Outcome measures
The primary outcomeswere fever, antibiotic therapy and length
of hospital stay. Fever was deﬁned as a body temperature 38 deg
Celsius. Antibiotic therapywas quantiﬁed as the number of days on
intravenous antibiotics. Length of hospital stay was calculated as
the number of days from admission to discharge; it was calculated
as a continuous outcome, as well as being analysed after being
dichotomised into those extending beyond 28 days or not.
The secondary outcomes were white cell count, abnormal chest
radiograph,mortality, treatment costs and the need formechanical
ventilation. The white cell count was measured on the ﬁfth
postoperative day, and was calculated by laboratory staff who
were unaware of the participants’ group allocation. Radiologists,
who were unaware of the participants’ group allocation, decided
whether there were any abnormalities on the participants’ chest
radiographs. Mortality and treatments costs were determined
fromhospital records. At discharge fromhospital, participantswho
had used the oscillating PEP device were questioned about any
adverse events associated with the device.
Data analysis
All participants completed the study as allocated, so analysis
was consistent with the intention-to-treat principle. Group data
Zhang et al: Oscillating PEP after thoracic and abdominal surgery18were summarised as means and SD. For continuous outcome
measures, between-group comparisons used the independent-
samples t-test and were reported as mean differences with 95% CI.
For dichotomous outcomes, between-group comparisons used the
chi-square test and were reported as relative risks with 95% CI.
Signiﬁcant results were also converted to ‘number needed to treat’.
All statistical tests were two-tailed, with an alpha level of
< 0.05 considered to be statistically signiﬁcant.Results
Compliance with the study protocol
One 16 year old was enrolled, despite being below the intended
age range for participants. All participants provided data for the
planned outcome measures, except that a white blood cell count
was unavailable for three experimental group participants and
four control group participants.Flow of participants, therapists and centres through the study
Between January 2009 and February 2010, 233 adult patients
undergoing thoracic and upper abdominal surgery in the three
hospitals located in Shanghai, China were screened for eligibility.
Of these, 30 were excluded: 22 did not meet the eligibility criteria,
six declined to participate, and informed consent was not obtained
from the remaining two participants. Therefore, 203 patients were
randomised – all of whom completed the study and provided data
for analysis, as shown in Figure 2.
The baseline characteristics of the two groups were similar, as
presented in Table 1.[(Figure_2)TD$FIG]
Figure 2. Flow of participaEffect of intervention
The ﬁrst primary outcome – the incidence of fever – was
signiﬁcantly reduced by the intervention. Speciﬁcally, the inci-
dence of fever was 39% in the control group and 22% in the
experimental group. This means that the experimental group had a
risk of fever that was 0.56 of the risk in the control group. This
‘relative risk’ estimate of 0.56 was statistically signiﬁcant (95% CI
0.36 to 0.87), as presented in Table 2. It also suggests that, on
average, for every six patients who undertook the oscillating PEP
intervention, one remained afebrile who would otherwise have
experienced a fever during their ﬁrst 28 postoperative days.
However, this estimate of six patients, as the number needed to
treat to prevent one case of fever, has some imprecision associated
with it. The true ‘number needed to treat’ could be as low as 3 or as
high as 22 patients.
The length of hospital stay was analysed in two ways: as a
continuous outcome and as a dichotomous outcome. When
analysed as a continuous outcome, length of stay was signiﬁcantly
reduced from 13.3 days (SD 8.7) in the control group to 10.7 days
(SD 7.1) in the experimental group, with a mean difference of –2.6
(95% CI –4.8 to –0.4), as shown in Table 3. The risk of prolonged
hospitalisation (ie,> 28 days)was 9% in the control group and 6% in
the experimental group, with a RR of 0.58 (95% CI 0.20 to 1.68), as
shown in Table 2.
The other primary outcomes were not signiﬁcantly improved
by the oscillating PEP intervention. The risk of requiring antibiotics
was 95% in the control group and 93% in the experimental group,
with a RR of 0.99 (95% CI 0.92 to 1.05), as shown in Table 2. The
number of days spent receiving antibiotic therapy was also not
signiﬁcantly affected by the intervention,with amean difference of
1.61 days less in the experimental group (95% CI –0.13 to 3.36), as
presented in Table 3.nts through the study.
Table 1







Gender (male), n (%) 61 (62) 63 (61)
Age (yr), mean (SD) 56 (10) 58 (12)
Body mass index (kg/m2), mean (SD) 23.5 (3.3) 23.3 (4.2)
Comorbidities, n (%)
chronic cardiovascular disease 19 (19) 18 (17)
chronic respiratory disease 1 (1) 2 (2)
other 12 (12) 9 (9)
Emergency operation, n (%) 26 (26) 26 (25)
Thoracic operation, n (%) 50 (51) 54 (52)
Upper abdominal operations, n (%) 49 (49) 50 (48)
laparotomy, n (%) 24 (24) 25 (24)
laparoscopy, n (%) 25 (25) 25 (24)
Total operative time (hr), mean (SD) 2.01 (1.42) 2.15 (1.48)
Max body temperature on Day 1
(deg C), mean (SD)
37.4 (0.5) 37.5 (0.5)
White blood cell count on Day 1
(109/L), mean (SD)
9.25 (4.18) 10.33 (4.24)
Table 2






Fever, n (%) 22 (22) 41 (39) 0.56 (0.36 to 0.87)
Hospital stay more
than 28 days, n (%)
5 (5) 9 (9) 0.58 (0.20 to 1.68)
Antibiotic therapy,
n (%)
93 (93) 99 (95) 0.99 (0.92 to 1.05)
Abnormal of chest
radiograph, n (%)
37 (37) 43 (42) 0.90 (0.64 to 1.27)
Exp=experimental group, Con= control group.
Research 19None of the secondary outcomes was signiﬁcantly affected by
the oscillating PEP intervention. The white cell count on Day 5 was
similar in the two groups, with a mean difference of 0.09 x 109/L.
The incidence of an abnormal chest radiograph was 42% in the
control group and 37% in the experimental group, with a RR of 0.90
(95% CI 0.64 to 1.27). Treatment costs were 3800 RMB cheaper in
the experimental group, but this was not statistically signiﬁcant
(95% CI –8400 to 900), as shown in Table 3. During the course of the
study, there were no deaths, and no other adverse events or
reactions were reported. Individual participant data are available
in Table 4 on the eAddenda.
Discussion
General anaesthesia with tracheal intubation has adverse
effects on the respiratory system. These effects begin with
anaesthetic induction and extend into the postoperative period.
General anaesthesia reduces functional residual capacity, with an
immediate and universal development of atelectasis in the
dependent regions of the lung.17 Secretion retention may also
occur and, when it does, it may contribute to the development of
postoperative pulmonary complications. The vibrations generated
by expiratory ﬂow in the oscillating PEP device are intended to
loosen and help the removal of retained airway secretions.18,19 The
oscillating PEP device used in the present study must be set at a
ﬁxed angle relative to gravity, which is most readily achieved in a
sitting position.20 The modiﬁed device in the present study
allowed the participants to use the device effectively in any body
position and eliminated any uncomfortable vibration of the teeth.
Its transparent design helped the user to ﬁnd the best position for
maximum vibration and comfort.21 As in previous studies,22 the
device was well tolerated and accepted by the study participants.
Adverse events or adverse reactions to the device were not
reported spontaneously during the study, nor when participants
were speciﬁcally questioned about this at discharge from hospital.Table 3




Length of hospital stay (d) 10.7 (7.1)
Antibiotic therapy (d) 7.23 (5.93)
White cell count on Day 5 (109/L) 7.66 (2.50) a
Total expense of treatment (RMB10 000) 2.07 (1.67)
Exp=experimental group, Con= control group.
a n=96,
b n=100.In the present study, some statistically signiﬁcant results were
observed. It is important to put these into context. The statistically
signiﬁcant reduction in the risk of fever was also clinically
substantial, because the best estimate was that for every six
patients who used the oscillating PEP, one would avoid fever who
would otherwise have experienced it. However, this estimate
carried some imprecision, with this estimate of six as the ‘number
needed to treat’ having a 95% CI from 3 to 22. If 22 patients had to
use the oscillating PEP to prevent one case of fever, this would not
be as clinically worthwhile. Also, fever may not have been an
indicator of a very severe PPC, because this result was not
accompanied by signiﬁcant reductions in antibiotic use or
radiological abnormalities. The other statistically signiﬁcant result
(ie, a 2.6 day reduction in length of hospital stay) was clinically
relevant to the centres in Shanghai. However, it is acknowledged
that other centres have shorter lengths of hospital stay, so the
potential to reduce them by 2.6 days with oscillating PEP may be
limited.
The present results should also be considered in the context of
other studies in this area. A previous single-centre study with a
relatively small sample size indicated that incentive spirometry in
addition to regular physiotherapy did not further reduce pulmo-
nary complications or hospital stay in postoperative lung and
oesophagus surgery patients.23 Silva and colleagues reported that
the addition of deep breathing exercises to physiotherapy-directed
early mobilisation did not further reduce PPCs, compared with
mobilisation alone.24 Mackay and colleagues reported that the
addition of deep breathing and coughing exercises to a physio-
therapist-directed program of earlymobilisation in high-risk, open
abdominal surgery patients did not signiﬁcantly reduce the
incidence of clinically signiﬁcant PPCs.25 However, both of these
studies had smaller sample sizes and were single-centre studies.
Another study reported no reduction in PPCs from respiratory
physiotherapy in elective pulmonary resection via open thoracot-
omy surgical patients, when compared to standard medical/
nursing care.26 Although the interventions in these studies had
similar aims (eg, improving ventilation and reducing secretion
retention) to the intervention in the present study, the results of
these studies are different from the present results. However, a
recent study with a larger sample size found that incentive
spirometry might be a favourable intervention for patients with a





Mean (SD) (95% CI)
13.3 (8.7) –2.6 (–4.8 to –0.4)
8.85 (6.62) 1.61 (–0.13 to 3.36)
7.76 (2.87) b 0.09 (–0.67 to 0.86)
2.44 (1.68) –0.38 (–0.84 to 0.09)
Zhang et al: Oscillating PEP after thoracic and abdominal surgery20respiratory disease or a history of smoking.27 Scholes and
colleagues3 and Agostini and colleagues28 reported risk factors
that predicted PPCs, including: duration of anaesthesia, surgical
category, current smoking, respiratory comorbidity, predicted
maximal oxygen uptake and a bodymass index over 30 kg/m2. This
high-risk population may beneﬁt from physiotherapy intervention
to minimise PPCs.
Currently, in most of the hospitals in China, there is no regular
standardised respiratory or physiotherapy care for postoperative
patients. The consensus statement29 regarding pulmonary compli-
cations after thoracic surgery, which was published in 2009 by the
ChineseAssociationof Thoracic Surgery, didnot report the incidence
of PPC in China and did not recommend physiotherapy for
prevention. Given the favourable results from the present study,
the favourable results in high-risk patients discussed above,25 and
evidence that physiotherapist-directed postoperative exercise
decreases pain and improves shoulder function over usual care
forpatients followingopenthoracotomy,physiotherapistsmayhave
the opportunity to gain referrals for patients in this area.16
From this randomised controlled study, it can be concluded that
in developing areas where physiotherapy is not standard, the use
of a modiﬁed oscillating PEP device results in fewer cases of fever
and reduced length of hospital stay in thoracic and upper
abdominal postoperative adult patients.
Footnotes:aFlutter1 VRP1, Tyco Healthcare, Germany.
eAddenda: Table 4 can be found online at doi:10.1016/
j.jphys.2014.11.013.
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